Clinical Trials Browser

Phase 2 × Carcinoma × Temozolomide × Clear all

NCT02605811 2019-03-28

Temozolomide in Preventing Brain Metastases in Small Cell Lung Cancer

Phase 2 Unknown

Brain Neoplasms, Carcinoma, Small Cell Lung Carcinoma